
### [NCIT:C40111](http://purl.obolibrary.org/obo/NCIT_C40111)
**Label:** Fallopian Tube Endometrioid Tumor

**Subclasses:** [NCIT:C40124](http://purl.obolibrary.org/obo/NCIT_C40124) (Fallopian Tube Carcinosarcoma), [NCIT:C40110](http://purl.obolibrary.org/obo/NCIT_C40110) (Borderline Fallopian Tube Endometrioid Tumor), [NCIT:C6279](http://purl.obolibrary.org/obo/NCIT_C6279) (Fallopian Tube Endometrioid Adenocarcinoma), 

**Class expressions from DL-Learner:**

- [UBERON:0000474](http://purl.obolibrary.org/obo/UBERON_0000474) (female reproductive system) 55.56%
- Thing 52.40%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36273](http://purl.obolibrary.org/obo/NCIT_C36273) (Small Lymphocytic Lymphoma with Plasmacytoid Differentiation))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36272](http://purl.obolibrary.org/obo/NCIT_C36272) (Chronic Lymphocytic Leukemia with Plasmacytoid Differentiation))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36271](http://purl.obolibrary.org/obo/NCIT_C36271) (T-Cell Prolymphocytic Leukemia, Cerebriform Cell Variant))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36270](http://purl.obolibrary.org/obo/NCIT_C36270) (T-Cell Prolymphocytic Leukemia, Small Cell Variant))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36261](http://purl.obolibrary.org/obo/NCIT_C36261) (Non-Hereditary Clear Cell Renal Cell Carcinoma))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36260](http://purl.obolibrary.org/obo/NCIT_C36260) (Hereditary Clear Cell Renal Cell Carcinoma))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36258](http://purl.obolibrary.org/obo/NCIT_C36258) (Lymphatic Spread))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36253](http://purl.obolibrary.org/obo/NCIT_C36253) (Bone Marrow Basophilia))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36252](http://purl.obolibrary.org/obo/NCIT_C36252) (Ineffective Hematopoiesis))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36250](http://purl.obolibrary.org/obo/NCIT_C36250) (Auer Rods Present))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36246](http://purl.obolibrary.org/obo/NCIT_C36246) (Megakaryoblasts 50 Percent or More of Bone Marrow Nucleated Cells))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36243](http://purl.obolibrary.org/obo/NCIT_C36243) (Erythroid Precursors 50 Percent or More of Bone Marrow Nucleated Cells))) 40.91%


